BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 1944423)

  • 1. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
    Shapiro ED; Berg AT; Austrian R; Schroeder D; Parcells V; Margolis A; Adair RK; Clemens JD
    N Engl J Med; 1991 Nov; 325(21):1453-60. PubMed ID: 1944423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
    N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
    Farr BM; Johnston BL; Cobb DK; Fisch MJ; Germanson TP; Adal KA; Anglim AM
    Arch Intern Med; 1995 Nov; 155(21):2336-40. PubMed ID: 7487259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
    Whitney CG; Farley MM; Hadler J; Harrison LH; Bennett NM; Lynfield R; Reingold A; Cieslak PR; Pilishvili T; Jackson D; Facklam RR; Jorgensen JH; Schuchat A;
    N Engl J Med; 2003 May; 348(18):1737-46. PubMed ID: 12724479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    Eskola J; Kilpi T; Palmu A; Jokinen J; Haapakoski J; Herva E; Takala A; Käyhty H; Karma P; Kohberger R; Siber G; Mäkelä PH;
    N Engl J Med; 2001 Feb; 344(6):403-9. PubMed ID: 11172176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study.
    Barricarte A; Castilla J; Gil-Setas A; Torroba L; Navarro-Alonso JA; Irisarri F; Arriazu M
    Clin Infect Dis; 2007 Jun; 44(11):1436-41. PubMed ID: 17479939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae colonization among patients with human immunodeficiency virus-1 who had received 23-valent polysaccharide pneumococcal vaccine.
    Lo YC; Lauderdale TL; Chang SY; Hsiao CF; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2009 Jun; 42(3):234-42. PubMed ID: 19812857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults.
    Benin AL; O'Brien KL; Watt JP; Reid R; Zell ER; Katz S; Donaldson C; Parkinson A; Schuchat A; Santosham M; Whitney CG
    J Infect Dis; 2003 Jul; 188(1):81-9. PubMed ID: 12825175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
    Motlová J
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal infections among vaccinated children in the United States.
    Park SY; Van Beneden CA; Pilishvili T; Martin M; Facklam RR; Whitney CG;
    J Pediatr; 2010 Mar; 156(3):478-483.e2. PubMed ID: 19962156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study.
    Dominguez A; Salleras L; Fedson DS; Izquierdo C; Ruiz L; Ciruela P; Fenoll A; Casal J
    Clin Infect Dis; 2005 May; 40(9):1250-7. PubMed ID: 15825026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.
    Broome CV; Facklam RR; Fraser DW
    N Engl J Med; 1980 Sep; 303(10):549-52. PubMed ID: 6995835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population.
    Romney MG; Hull MW; Gustafson R; Sandhu J; Champagne S; Wong T; Nematallah A; Forsting S; Daly P
    Clin Infect Dis; 2008 Sep; 47(6):768-74. PubMed ID: 18690803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
    Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.
    Hofmann J; Cetron MS; Farley MM; Baughman WS; Facklam RR; Elliott JA; Deaver KA; Breiman RF
    N Engl J Med; 1995 Aug; 333(8):481-6. PubMed ID: 7623880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.